✦ LIBER ✦

Age-Specific Effectiveness and Safety of Newly Initiated Insulin Therapy in Japanese Patients with Uncontrolled Diabetes

✍ Scribed by Shiga, Takayoshi; Yokokawa, Hirohide; Taneda, Yoshinobu; Sugihara, Eiichiro; Meijyo, Mayumi; Mitsuhashi, Kazunori; Hisaoka, Teruhiko; Isonuma, Hiroshi

Book ID: 121587693
Publisher: Springer-Verlag
Year: 2013
Tongue: English
Weight: 453 KB
Volume: 4
Category: Article
ISSN: 1869-6953
DOI: 10.1007/s13300-013-0049-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acarbose and metabolic control in patien

Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy

✍ O. Schnell; G. Mertes; E. Standl; Acarbose–Insulin Combination Study Group 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Safety and Effectiveness of U-500 Insuli

Safety and Effectiveness of U-500 Insulin Therapy in Patients with Insulin-Resistant Type 2 Diabetes Mellitus

✍ Dr. Suzanne L. Quinn; Dr. M. Cecilia Lansang; Dr. Deanna Mina 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Efficacy and safety of sitagliptin add-o

Efficacy and safety of sitagliptin add-on therapy in Japanese patients with type 2 diabetes on insulin monotherapy

✍ Takashi Kadowaki, Naoko Tajima, Masato Odawara… 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 625 KB

Effects on post-prandial glucose and AGE

Effects on post-prandial glucose and AGE precursors from two initial insulin strategies in patients with Type 2 diabetes uncontrolled by oral agents

✍ Olga V. Sakharova; Ranee R. Lleva; James D. Dziura; Geralyn R. Spollett; Scott K 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Efficacy and safety of insulin glulisine

Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus

✍ R. Kawamori; T. Kadowaki; H. Ishii; M. Iwasaki; Y. Iwamoto 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

Initiating insulin therapy with, or swit

Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix® 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE™ observational study

✍ P. Valensi; M. Benroubi; V. Borzi; J. Gumprecht; R. Kawamori; J. Shaban; S. Shah 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB